Terms: = Prostate cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Staging
8 results:
1. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.
Zhou K; Li C; Chen T; Zhang X; Ma B
Front Endocrinol (Lausanne); 2023; 14():1111277. PubMed ID: 36817592
[TBL] [Abstract] [Full Text] [Related]
2. Correlation between periodontitis and prostate-specific antigen levels in the elderly Chinese male population.
Mao M; Zhu H; Xie Y; Ni D; Zhu F; Chen Q
BMC Oral Health; 2022 May; 22(1):163. PubMed ID: 35524291
[TBL] [Abstract] [Full Text] [Related]
3. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk prostate cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
[TBL] [Abstract] [Full Text] [Related]
4. Should abdominal sequences be included in prostate cancer MR staging studies?
McEvoy SH; Lavelle LP; Purcell YM; Quinlan DM; Skehan SJ; Collins CD; McMahon CJ
Eur J Radiol; 2015 Jun; 84(6):1019-22. PubMed ID: 25795196
[TBL] [Abstract] [Full Text] [Related]
5. Incidental findings at initial imaging workup of patients with prostate cancer: clinical significance and outcomes.
Elmi A; Tabatabaei S; Talab SS; Hedgire SS; Cao K; Harisinghani M
AJR Am J Roentgenol; 2012 Dec; 199(6):1305-11. PubMed ID: 23169722
[TBL] [Abstract] [Full Text] [Related]
6. [Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy].
Ojea Calvo A; Núñez López A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Gómez-González MC; González Piñeiro A; Otero García M; Nogueira March JL
Actas Urol Esp; 2003 Jun; 27(6):428-37. PubMed ID: 12918149
[TBL] [Abstract] [Full Text] [Related]
7. Serum soluble fas level for detection and staging of prostate cancer.
Furuya Y; Fuse H; Masai M
Anticancer Res; 2001; 21(5):3595-8. PubMed ID: 11848529
[TBL] [Abstract] [Full Text] [Related]
8. Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated?
D'Amico AV; Davis A; Vargas SO; Renshaw AA; Jiroutek M; Richie JP
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):587-90. PubMed ID: 10078642
[TBL] [Abstract] [Full Text] [Related]
